Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)
To access this article, please choose from the options below
PII: S0002-9149(04)01873-9
doi:10.1016/j.amjcard.2004.11.020
© 2005 Excerpta Medica Inc. All rights reserved.
